Sparidans RW

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Pharmacokinetics of the KRAS(G12C) inhibitor adagrasib is limited by CYP3A and ABCB1, and influenced by binding to mouse plasma carboxylesterase 1c - Loos_2023_Biomed.Pharmacother_166_115304
Author(s) : Loos NHC , Retmana IA , Rijmers J , Wang Y , Gan C , Lebre MC , Sparidans RW , Beijnen JH , Schinkel AH
Ref : Biomed Pharmacother , 166 :115304 , 2023
Abstract : Loos_2023_Biomed.Pharmacother_166_115304
ESTHER : Loos_2023_Biomed.Pharmacother_166_115304
PubMedSearch : Loos_2023_Biomed.Pharmacother_166_115304
PubMedID: 37586117

Title : P-Glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain and Blood Disposition of the mTOR Inhibitor Everolimus (Afinitor) in Mice - Tang_2014_Clin.Cancer.Res_20_3133
Author(s) : Tang SC , Sparidans RW , Cheung KL , Fukami T , Durmus S , Wagenaar E , Yokoi T , van Vlijmen BJ , Beijnen JH , Schinkel AH
Ref : Clin Cancer Research , 20 :3133 , 2014
Abstract : Tang_2014_Clin.Cancer.Res_20_3133
ESTHER : Tang_2014_Clin.Cancer.Res_20_3133
PubMedSearch : Tang_2014_Clin.Cancer.Res_20_3133
PubMedID: 24727322